Trial Details
Not recruitingBasic Information
| Clinical ID | c3200 |
|---|---|
| Identifier | NCT01599702 |
| Trial Title | A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease (PROMISE) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | Drug: Iron Isomaltoside 1000 |
Participant Information
| Sponsor | Pharmacosmos A/S |
|---|---|
| City | - |
| Country/Region | Denmark;Sweden |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |